Amgen Inc (AMGN) Stock Analysis
Amgen Inc (AMGN) is a publicly traded company in the HEALTHCARE sector. It trades at $328.26, carries a market capitalization of $177.63B, a price-to-earnings ratio of 22.89, a dividend yield of 0.03%. This page summarizes the public market data, fundamentals, and frequently asked questions for AMGN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.
Sector: HEALTHCARE - DRUG MANUFACTURERS - GENERAL
Exchange: NASDAQ
Key Metrics
- Price: $328.26
- Market Cap: $177.63B
- P/E Ratio: 22.89
- EPS: $14.38
- Dividend Yield: 0.03%
- 52-Week High: $388.36
- 52-Week Low: $260.01
Market Sentiment
Amgen Inc currently has a Bullish sentiment score of 0.21.
About Amgen Inc
Amgen Inc. is a prominent multinational biopharmaceutical company headquartered in Thousand Oaks, California, renowned for its innovative therapies rooted in recombinant DNA technology. Specializing in oncology, nephrology, and inflammation, Amgen leverages its expertise in molecular biology to develop and commercialize biologic products that enhance patient outcomes. With a robust drug pipeline and a strong competitive position in the biotechnology sector, Amgen remains at the forefront of m...
GNG Research Analysis
GNG Research scores Amgen Inc (AMGN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for AMGN.
Frequently Asked Questions
What is AMGN's current dividend yield?
Amgen Inc (AMGN) has a current dividend yield of 0.03%.
Does AMGN pay dividends?
Yes, Amgen Inc pays dividends with a current yield of 0.03%.
What is AMGN's P/E ratio?
Amgen Inc has a price-to-earnings (P/E) ratio of 22.89.
What is AMGN's market cap?
Amgen Inc (AMGN) has a market capitalization of $177.63B with a current stock price of $328.26.